Common Adverse Events Researchers Track in Phase 2 and Phase 3 Across retatrutide side effects clinical trials queries, the same adverse-event cluster appears repeatedly: nausea, vomiting, diarrhea, constipation, decreased appetite, abdominal pain, back pain, and fatigue or tiredness
In some patients, symptoms do not correspond to the organic changes observed under endoscopy, 3 and conventional treatment strategies such as proton pump inhibitors (PPIs) are ineffective for a subset of patients
Although the number of beige adipocytes did not increase, they displayed a more thermogenic phenotype characterized by smaller LDs, elevated expression of uncoupling protein 1 ( UCP1 ) and HSL , and enhanced glucose utilization, all features consistent with increased mitochondrial uncoupling and browning
[DOI] [PMC free article] [PubMed] [Google Scholar] 57.Di Filippo M., Chisserini D., Tozzi A., Picconi B., Calabresi P